Exploring Partnerships and Clinical Innovation in New York

  • Home
  • Newsroom
  • Exploring Partnerships and Clinical Innovation in New York
Exploring Partnerships and Clinical Innovation in New York - Axcellant

Exploring Partnerships and Clinical Innovation in New York

  1. sie 21, 2025

The Axcellant team recently traveled to New York to meet with research partners and clinical collaborators from across the U.S.

The visit included working sessions focused on upcoming trials and regulatory planning, as well as our AI-powered medical device project for the early detection of congenital heart defects. These conversations are helping shape the next steps in our clinical development roadmap.

We also continued preparations for opening our new U.S. office — a move that will strengthen our ability to work closely with sponsors and research teams in North America.

Beyond the meetings, the trip offered space for team reflection and strategic thinking — sometimes the best ideas come outside of meeting rooms.

Thank you to everyone who took the time to meet with us. We look forward to continuing the conversations and turning shared plans into action.

Resources

Axcellant Establishes Advisory Board to Strengthen Clinical and Strategic Leadership

Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…

One trial is no longer enough. Regulators on both sides of the Atlantic are building a new model of clinical evidence

The FDA and the European Commission are changing the rules of the game simultaneously. The shift is from a single…

Imaging Core Lab in Nuclear Medicine: Standardization, Quality Control, and Regulatory Alignment in Clinical Trials 

Modern nuclear medicine is a high-tech discipline that requires advanced facilities, infrastructure, qualified staff, and know-how. The reliable supply of radionuclides,…